Tech Company Financing Transactions

Imbed Biosciences Funding Round

Private investors participated in a $1.1 million venture round for Imbed Biosciences. The round closed on 10/31/2018.

Transaction Overview

Company Name
Announced On
10/31/2018
Transaction Type
Venture Equity
Amount
$1,055,120
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 14 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5520 Nobel Dr. 100
Fitchburg, WI 53711
USA
Email Address
Overview
Imbed's vision is to develop next-generation medical devices that can reduce patient pain and costs for management of burns, chronic wounds, hernia meshes, gastro-intestinal defects, and dural membranes.
Profile
Imbed Biosciences LinkedIn Company Profile
Social Media
Imbed Biosciences Company Twitter Account
Company News
Imbed Biosciences News
Facebook
Imbed Biosciences on Facebook
YouTube
Imbed Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ankit Agarwal
  Ankit Agarwal LinkedIn Profile  Ankit Agarwal Twitter Account  Ankit Agarwal News  Ankit Agarwal on Facebook
Co-Founder
Nicholas Abbott
  Nicholas Abbott LinkedIn Profile  Nicholas Abbott Twitter Account  Nicholas Abbott News  Nicholas Abbott on Facebook
Co-Founder
Charles Czuprynski
  Charles Czuprynski LinkedIn Profile  Charles Czuprynski Twitter Account  Charles Czuprynski News  Charles Czuprynski on Facebook
Co-Founder
Jonathan McAnulty
  Jonathan McAnulty LinkedIn Profile  Jonathan McAnulty Twitter Account  Jonathan McAnulty News  Jonathan McAnulty on Facebook
Co-Founder
Christopher Murphy
  Christopher Murphy LinkedIn Profile  Christopher Murphy Twitter Account  Christopher Murphy News  Christopher Murphy on Facebook
Co-Founder
Michael Schurr
  Michael Schurr LinkedIn Profile  Michael Schurr Twitter Account  Michael Schurr News  Michael Schurr on Facebook
VP - Bus. Development
Gary Robinson
  Gary Robinson LinkedIn Profile  Gary Robinson Twitter Account  Gary Robinson News  Gary Robinson on Facebook
VP - Product Management
Jeffrey Dalsin
  Jeffrey Dalsin LinkedIn Profile  Jeffrey Dalsin Twitter Account  Jeffrey Dalsin News  Jeffrey Dalsin on Facebook
VP - R & D
Gaurav Pranami
  Gaurav Pranami LinkedIn Profile  Gaurav Pranami Twitter Account  Gaurav Pranami News  Gaurav Pranami on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/31/2018: Freebird venture capital transaction
Next: 10/31/2018: Terns Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary